Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Traws Pharma, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 26 | 30 | +4 |
| Shares | 1.86M | 3.03M | +1.17M (+62.9%) |
| Value | $1.88M | $1.36M | −$525.5K (−27.9%) |
New holders (8)
Institutions that held Traws Pharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 1,045,261 | $466.9K | 0.01% |
| Virtu Financial LLC | 27,356 | $12.0K | 0.00% |
| Jane Street Group, LLC | 25,062 | $11.2K | 0.00% |
| Ground Swell Capital, LLC | 14,047 | $6.28K | 0.01% |
| Mather Group, LLC. | 2,400 | $2.42K | 0.00% |
| Bank of America Corp | 209 | $93 | 0.00% |
| Pacific Capital Wealth Advisors, Inc | 66 | $29 | 0.00% |
| Simplex Trading, LLC | 1,569 | $0 | 0.00% |
Sold out (4)
Institutions that held Traws Pharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Two Sigma Advisers, LP | 73,066 | $73.8K |
| Two Sigma Investments, LP | 37,987 | $38.4K |
| Old Point Trust & Financial Services N A | 166 | $168 |
| Wells Fargo & Company | 164 | $166 |